Anixa Biosciences, Inc. share price logo

Anixa Biosciences, Inc. Share Price

NASDAQ: ANIX

Small Cap

$2.60

-0.01

(-0.38%)

as on

Anixa Biosciences, Inc. Stock Performance

as on March 25, 2026 at 6:58 am IST

  • Day's Low

    Day's High

    $2.45
    $2.66
    downward going graph

    5.77%

    Downside

    2.31%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.33
    $5.46
    downward going graph

    10.35%

    Downside

    109.87%

    Upside

    downward going graph

Anixa Biosciences, Inc. share price movements today

Previous Close
$2.61
Open
$2.59
Volume
806.0K
Day's Low - High
$2.45 - $2.66
52 Week Low - High
$2.33 - $5.46

Anixa Biosciences, Inc. Historical Returns

1 Month Return
-13.58 %
3 Month Return
-23.68 %
1 Year Return
-17.14 %
3 Year Return
-40.14 %
5 Year Return
-44.82 %

Anixa Biosciences, Inc. Stock Fundamentals & Key Indicators

Check Anixa Biosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$88.8M

EPS (TTM)

-0.36

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-13.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-68.07%

Anixa Biosciences, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anixa Biosciences, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Anixa Biosciences, Inc. image
Anixa Biosciences, Inc.
BUY$88.8M-44.82%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Stock Returns calculator for Anixa Biosciences, Inc. Stock including INR - Dollar returns

The Anixa Biosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Anixa Biosciences, Inc. investment value today

Current value as on today

₹92,080

Returns

₹7,920

(-7.92%)

Returns from Anixa Biosciences, Inc. Stock

₹17,460 (-17.46%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Anixa Biosciences, Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Anixa Biosciences, Inc.. Average target price of $10.75

Anixa Biosciences, Inc. Share Price Target

Get share price movements and forecasts by analysts on Anixa Biosciences, Inc..

What analysts predicted

75.81%UPSIDE

Target Price

$10.75

Current Price

$2.6

Analyzed by

7 Analysts

Target

$10.75

Anixa Biosciences, Inc. target price $10.75, a slight upside of 75.81% compared to current price of $2.6. According to 7 analysts rating.

Anixa Biosciences, Inc. Stock’s Investor Sentiment and Interest

Search interest for Anixa Biosciences, Inc. Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-30% versus previous 30 day period

Anixa Biosciences, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Oct 2023
Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Total Revenue
0
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
0
0
0
0
Operating Income
-3
-3
-3
-3
-3
-3
-3
-2
-2
-2
EBITDA
-3
-3
-3
-3
-3
-3
-2
-2
-2
-2
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-3
-3
-3
-2
-3
-2
-2
-2
-2
Income Tax Expense
0
0
0
0
-
-
-
-
-
-
Net Income
-2
-3
-3
-3
-2
-3
-2
-2
-2
-2
Net Profit Margin
-1724.36%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Anixa Biosciences, Inc. Annual Profit & Loss

All numbers in Millions USD

Oct 2016
Oct 2017
Oct 2018
Oct 2019
Oct 2020
Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Total Revenue
0
0
1
0
-
0
2,469
0
-
-
Gross Profit
0
0
0
0
0
0
2,468
0
0
0
Operating Income
-4
-6
-13
-11
-9
-13
-13
-11
-13
-11
EBITDA
-4
-4
-13
-11
-10
-13
-13
-10
-12
-11
Interest Expense
0
0
-
-
0
0
0
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-5
-14
-11
-10
-13
-13
-9
-12
-11
Income Tax Expense
0
0
0
0
0
0
0
0
0
-
Net Income
-5
-5
-13
-11
-10
-12
-13
-9
-12
-10
Net Profit Margin
-1672.14%
-1381.79%
-1258.07%
-4658.82%
0.00%
-2528.64%
-0.55%
-4671.90%
0.00%
0.00%

Anixa Biosciences, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Net Income
-3
-3
-3
-2
-3
-2
-2
-2
-2
Operating Cash Flow
-2
-2
-2
0
-2
-1
-1
-1
-2
Investing Cash Flow
0
2
2
0
2
2
0
0
1
Financing Cash Flow
2
0
0
0
0
0
1
0
1
Change in Cash
0
0
0
0
0
0
0
0
0

Anixa Biosciences, Inc. Annual Cash Flow

All numbers in Millions USD

Oct 2017
Oct 2018
Oct 2019
Oct 2020
Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Net Income
-5
-14
-11
-10
-13
-13
-9
-12
-11
Operating Cash Flow
-3
-4
-4
-6
-4
-6
-6
-7
-7
Investing Cash Flow
-2
1
0
0
-3
-10
-5
4
4
Financing Cash Flow
7
2
5
9
31
0
0
3
2
Change in Cash
0
0
0
2
22
-16
-11
0
0

Global Institutional Holdings in Anixa Biosciences, Inc.

Funds
Holdings
Geode Capital Management, LLC
1.05%
LPL Financial Corp
0.26%
Bank of America Corp
0.64%
CI Private Wealth LLC
0.22%
HighTower Advisors, LLC
0.12%
See all

Anixa Biosciences, Inc. News & Key Events

  • img

    Today's Timeline - 16 September

    Tue, 07:10 PM

    -

    Anixa Biosciences stock has returned 51.7% this year, with EPS estimates rising 7.9% over the past three months.

    Tue, 10:00 PM

    -

    Anixa completes dosing in fourth cohort of Phase 1 ovarian cancer CAR-T trial, showing positive safety profile.

    Tue, 11:35 PM

    -

    Anixa reports improved financial performance, sufficient cash runway, and files US$200 million Shelf Registration for future funding.

Insights on Anixa Biosciences, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Anixa Biosciences, Inc. has experienced a drawdown of -40.1%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 29.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 16.1% return, outperforming this stock by 33.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ANIX stock has moved down by -5.8%

About Anixa Biosciences, Inc.

itus develops and acquires patented technologies for the purposes of patent monetization and patent assertion. the company currently has 8 patent portfolios in the areas of key based web conferencing encryption, encrypted cellular communications, nano field emission display (“nfed”), micro electro mechanical systems display (“mems”), j-channel window frame construction, vpn multicast communications, internet telephonic gateway, and enhanced auction technologies. itus’s management team has over 30 years of combined experience in patent monetization and patent assertion, and has generated in excess of $150 million patent licensing revenues
OrganisationAnixa Biosciences, Inc.
Headquarters3150 Almaden Expressway, San Jose, CA, United States, 95118
IndustryElectronic Technology
CEODr. Amit Kumar Ph.D.
E-voting on sharesClick here to vote

Key Management of Anixa Biosciences, Inc.

Name

Title

Dr. Amit Kumar Ph.D.

CEO, Chairman & Co-Chair of CBAB

Mr. Michael J. Catelani CPA, MBA

President, COO, CFO & Corporate Secretary

Dr. Pamela D. Garzone Ph.D.

Chief Development Officer & Chair Breast Cancer Clinical Advisory Board

FAQs

What is Anixa Biosciences, Inc. share price today?

Anixa Biosciences, Inc. share price today is $2.6 as on at the close of the market. Anixa Biosciences, Inc. share today touched a day high of $2.66 and a low of $2.45.

What is the 52 week high and 52 week low for Anixa Biosciences, Inc. share?

Anixa Biosciences, Inc. share touched a 52 week high of $5.46 on and a 52 week low of $2.33 on . Anixa Biosciences, Inc. stock price today i.e. is closed at $2.6,which is 52.35% down from its 52 week high and 11.54% up from its 52 week low.

What is Anixa Biosciences, Inc.'s market capitalisation today?

Anixa Biosciences, Inc. market capitalisation is $0.00T as on .

How to invest in Anixa Biosciences, Inc. Stock (ANIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Anixa Biosciences, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anixa Biosciences, Inc. Shares that will get you 0.5769 shares as per Anixa Biosciences, Inc. share price of $2.6 per share as on March 25, 2026 at 1:28 am IST.

What is the minimum amount required to buy Anixa Biosciences, Inc. Stock (ANIX) from India?

Indian investors can start investing in Anixa Biosciences, Inc. (ANIX) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Anixa Biosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Anixa Biosciences, Inc. share’s latest price of $2.6 as on March 25, 2026 at 1:28 am IST, you will get 3.8462 shares of Anixa Biosciences, Inc.. Learn more about fractional shares .

What are the returns that Anixa Biosciences, Inc. has given to Indian investors in the last 5 years?

Anixa Biosciences, Inc. stock has given -44.82% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?